Picture of LAVA Therapeutics NV logo

LVTX — LAVA Therapeutics NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Lava Therapeutics Provides Updates On Clinical Programs, Extends Cash Runway

June 14 (Reuters) - LAVA Therapeutics NV  LVTX.O :
    * LAVA THERAPEUTICS PROVIDES UPDATES ON CLINICAL PROGRAMS
AND
EXTENDS THE CASH RUNWAY
    * LAVA THERAPEUTICS NV - ASSOCIATED COST SAVINGS AND
INITIATIVES
ARE EXPECTED TO EXTEND CASH RUNWAY FURTHER INTO 2026
    * LAVA THERAPEUTICS NV - LAVA-051 PHASE 1/2A CLINICAL TRIAL
WILL
BE DISCONTINUED
    * LAVA THERAPEUTICS NV - DECISION TO DISCONTINUE LAVA-051'S
CLINICAL TRIAL FOLLOWS A RECENT REVIEW OF COMPETITIVE LANDSCAPE
THAT HAS CONTINUED TO EVOLVE

Source text for Eikon:  ID:nGNXbStjXZ 
Further company coverage:  LVTX.O 

 (reuters.briefs@thomsonreuters.com)

Recent news on LAVA Therapeutics NV

See all news